The final results of the US FDA, EMA, TGA joint manufacturing facility inspection programme will make for interesting reading for API producers as they strongly hint the approach is here to stay.
The number of in-transit pharmaceutical robberies in the US has been sliced by almost half since last year, according to FreightWatch’s Biannual Cargo Theft Report.
Preclinical service revenue at Charles River slumped to its lowest level since 2005 in the second quarter, but margin gains helped earnings beat analysts’ estimates.
Intelliject has received tentative US FDA approval for its e-cue ‘talking’ autoinjector, setting the device maker up for a potentially lucrative partnership with licensee French drug giant Sanofi.
The EDQM has suggested Google Earth as a potential source of GPS co-ordinate data for manufacturing sites that must be supplied in CEP applications under recently introduced requirements.
The pharma biobanking and compound management services sector welcomed its newest member last week with Brooks Automation’s acquisition of Nexus Biosystems.
The CEO of Covance has warned it will be “very, very difficult” for CROs expanding through M&A to integrate assets, and the process could see clients go elsewhere.
US drugmaker Merck & Co announced plans to reduce its workforce by 13 percent, or 13,000 employees, in a bid to cut costs and focus its efforts in emerging markets.
Robert Bosch Packaging Technology has sold a filling line to US firm Pharmalucence Partners, which is expanding its contract pharmaceutical manufacturing business.
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, GlaxoSmithKline, Croda and Provectus.
An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.
Pharmaceutics International (Pii) has expanded its range of formulation and process development services with the addition of bioavailability boosting hot-melt extrusion (HME) capabilities.
INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.
Researchers at Alexandria University believe they can solve problems in the delivery of erectile dysfunction medication with the help of nanotechnology.
CMO Angel Biotechnologies has called in UK-based engineering group WH Partnership to help re-commissioning its GMP standard biomanufacturing facility in Cramlington near Newcastle-upon-Tyne.
In June global drug giant Pfizer began what it described as the world’s first ‘virtual trial’ using mobile technology to collect data from patients in their own homes rather than at research sites.
PPD posted an improved set of financials for Q2 days after announcing a review of its long-term plan and capital structure following speculation it was looking for a buyer.
Express Script will take over fellow PBM Medco after a definitive merger agreement was unanimously approved by the boards of directors of both companies.
The acquisition of site optimisation specialist Firecrest is good news for customers including US drug giant Pfizer says Alan Morgan, group president of clinical services at Icon.
India’s Central drugs standard control organisation (CDSCO) has issued new draft guidance of clinical trials and new drug approvals that pave the way for potential electronic submissions.